BACKGROUND: We had a case in which three consecutive pregnancies resulted in birth of three children with an orofacial cleft. Their mother suffered from bronchial asthma and was treated using symbicort (corticosteroid budesonide plus bronchodilator formoterol) during her pregnancies. A hypothesis was assessed: these anti-asthmatics can induce an orofacial cleft in experimental model. MATERIALS AND METHODS: A single administration of one of five increasing doses (including therapeutically used ones) of Symbicort, budesonide or formoterol was injected into the amnion of a chick embryo on day 4 or 5 of incubation. The teratogenic/lethal effects of the anti-asthmatics were assessed on a total of 600 embryos. RESULTS: For budesonide, the teratogenic/lethal effect started at a dose 0.003 μg per embryo, for formoterol at 0.3 μg and for Symbicort 0.03 μg. Orofacial clefts and gastroschisis after exposure were found for all three anti-asthmatics. Heart septum defects occurred after exposure to formoterol. CONCLUSION: The present results support those clinical/epidemiological studies pointing out that anti-asthmatics have the potential to induce orofacial clefts, gastroschisis and heart malformations during prenatal development in human.

Cleft Centre Clinic of Plastic Surgery Kralovske Vinohrady University Hospital and 3rd Faculty of Medicine Charles University Prague Czech Republic

Cleft Centre Clinic of Plastic Surgery Kralovske Vinohrady University Hospital and 3rd Faculty of Medicine Charles University Prague Czech Republic;

Institute of Anatomy 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Histology and Embryology 3rd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Schatz M. The efficacy and safety of asthma medications during pregnancy. Semin Perinatol. 2001;25(3):145–152. doi: 10.1053/sper.2001.24569. PubMed DOI

Sawicki E, Stewart K, Wong S, Paul E, Leung L, George J. Management of asthma by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol. 2012;52(2):183–138. doi: 10.1111/j.1479-828X.2011.01385.x. PubMed DOI

Jølving LR, Nielsen J, Kesmodel US, Nielsen RG, Beck-Nielsen SS, Nørgård BM. Prevalence of maternal chronic diseases during pregnancy – a nationwide population based study from 1989 to 2013. Acta Obstet Gynecol Scand. 2016;95(11):1295–1304. doi: 10.1111/aogs.13007. PubMed DOI

Clifton VL. Managing asthma in pregnancy: effects on future child health. Lancet Respir Med. 2019;7(6):485–486. doi: 10.1016/S2213-2600(19)30149-3. PubMed DOI

Taytard J, Lacin F, Nguyen TLT, Boizeau P, Alberti C, Beydon N. Children with uncontrolled asthma and significant reversibility might show hypoxaemia. Eur J Pediatr. 2020;179(6):999–1005. doi: 10.1007/s00431-020-03600-z. PubMed DOI

Rance K, O’Laughlen MC. Managing asthma during pregnancy. J Am Assoc Nurse Pract. 2013;25(10):513–521. doi: 10.1002/2327-6924.12052. PubMed DOI

Tan KS, Thomson NC. Asthma in pregnancy. Am J Med. 2000;109(9):727–733. doi: 10.1016/s0002-9343(00)00615-x. PubMed DOI

Dombrowski MP, Schatz M. Asthma in pregnancy. Clin Obstet Gynecol. 2010;53(2):301–310. doi: 10.1097/GRF.0b013e3181de8906. PubMed DOI

Murphy VE, Wang G, Namazy JA, Powell H, Gibson PG, Chambers C, Schatz M. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG. 2013;120(7):812–822. doi: 10.1111/1471-0528.12224. PubMed DOI

Murphy VE, Schatz M. Asthma in pregnancy: a hit for two. Eur Respir Rev. 2014;23(131):64–68. doi: 10.1183/09059180.00008313. PubMed DOI PMC

Bonham CA, Patterson KC, Strek ME. Asthma Outcomes and Management During Pregnancy. Chest. 2018;153(2):515–527. doi: 10.1016/j.chest.2017.08.029. PubMed DOI PMC

Lasserson TJ, Ferrara G, Casali L. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst Rev. 2011;(12):CD004106. doi: 10.1002/14651858.CD004106.pub4. PubMed DOI PMC

Kew KM, Karner C, Mindus SM, Ferrara G. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;12:CD009019. doi: 10.1002/14651858.CD009019.pub2. PubMed DOI PMC

Murphy VE. Managing asthma in pregnancy. Breathe (Sheff) 2015;11(4):258–267. doi: 10.1183/20734735.007915. PubMed DOI PMC

Namazy J, Schatz M. The Treatment of Allergic Respiratory Disease During Pregnancy. J Investig Allergol Clin Immunol. 2016;26(1):1–7. quiz 2p following 7. PubMed

National Heart, Lung and Blood Institute , National Asthma Education and Prevention Program Asthma and Pregnancy Working Group NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol. 2005;115(1):34–46. doi: 10.1016/j.jaci.2004.10.023. PubMed DOI

Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ, National Birth Defects Prevention Study Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585.e1–7. doi: 10.1016/j.ajog.2007.05.046. discussion 683-684, e1-7. PubMed DOI

Blais L, Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. J Allergy Clin Immunol. 2008;121(6):1379–1384, 1384.e1. doi: 10.1016/j.jaci.2008.02.038. PubMed DOI

Rocklin RE. Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy. Reprod Toxicol. 2011;32(2):189–197. doi: 10.1016/j.reprotox.2011.05.023. PubMed DOI

Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18(1):93–101. doi: 10.1016/j.reprotox.2003.10.007. PubMed DOI

Lin S, Munsie JP, Herdt-Losavio ML, Bell E, Druschel C, Romitti PA, Olney R, National Birth Defects Prevention Study Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol. 2008;168(1):73–79. doi: 10.1093/aje/kwn098. PubMed DOI PMC

Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183(7):796–804. doi: 10.1503/cmaj.101063. PubMed DOI PMC

Bay Bjørn AM, Ehrenstein V, Hundborg HH, Nohr EA, Sørensen HT, Nørgaard M. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. 2014;21(2):73–80. doi: 10.1097/MJT.0b013e3182491e02. PubMed DOI

Skuladottir H, Wilcox AJ, Ma C, Lammer EJ, Rasmussen SA, Werler MM, Shaw GM, Carmichael SL. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499–506. doi: 10.1002/bdra.23248. PubMed DOI PMC

Garne E, Hansen AV, Morris J, Zaupper L, Addor MC, Barisic I, Gatt M, Lelong N, Klungsøyr K, O’Mahony M, Nelen V, Neville AJ, Pierini A, Tucker D, de Walle H, Wiesel A, Loane M, Dolk H. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study. J Allergy Clin Immunol. 2015;136(6):1496–1502.e7. doi: 10.1016/j.jaci.2015.05.043. PubMed DOI

Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C. Maternal asthma, asthma medication use, and the risk of congenital heart defects. Birth Defects Res A Clin Mol Teratol. 2009;85(2):161–168. doi: 10.1002/bdra.20523. PubMed DOI

Munsie JW, Lin S, Browne ML, Campbell KA, Caton AR, Bell EM, Rasmussen SA, Romitti PA, Druschel CM, National Birth Defects Prevention Study Maternal bronchodilator use and the risk of orofacial clefts. Hum Reprod. 2011;26(11):3147–3154. doi: 10.1093/humrep/der315. PubMed DOI PMC

Eltonsy S, Kettani FZ, Blais L. Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review. Respir Med. 2014;108(1):9–33. doi: 10.1016/j.rmed.2013.07.009. PubMed DOI

Jelinek R, Peterka M, Rychter Z. Chick embryotoxicity screening test–130 substances tested. Indian J Exp Biol. 1985;23(10):588–595. PubMed

Peterka M, Jelínek R, Pavlík A. Embryotoxicity of 25 psychotropic drugs: a study using CHEST. Reprod Toxicol. 1992;6(4):367–374. doi: 10.1016/0890-6238(92)90201-4. PubMed DOI

Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. J Morphol. 1951;88(1):49–92. PubMed

Peterka M, Jelinek R. Origin of hydrocortisone induced orofacial clefts in the chick embryo. Cleft Palate J. 1983;20(1):35–46. PubMed

Jelínek R, Pavlík A, Peterka M. Glucocorticoid receptor-mediated teratogenesis in the chick embryo. Teratog Carcinog Mutagen. 1983;3(1):1–7. doi: 10.1002/1520-6866(1990)3:1<1::aid-tcm1770030102>3.0.co;2-q. PubMed DOI

Peterka M, Peterková R, Likovský Z. Cleft beak induced by hydrocortisone in the chick is prevented by increased cell division after experimental reduction of amniotic fluid. Anat Embryol (Berl) 1997;195(4):387–391. doi: 10.1007/s004290050059. PubMed DOI

Dixon WJ, Massey FJ. McGraw-Hill, New York. 1969. Introduction to statistical analysis; p. pp. 77.

Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) 1986;292(6522):746–750. doi: 10.1136/bmj.292.6522.746. PubMed DOI PMC

Baxter H, Fraser FC. The production of congenital defects in the offspring of female mice treated with cortisone. A preliminary report. McGill Med J. 1950;19(4):245–249. PubMed

Fraser FC, Fainstat TD. Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report. Pediatrics. 1951;8(4):527–533. PubMed

Ziejewski MK, Solomon HM, Stanislaus D, Clark RL, White TE, Apostoli AR. The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B) Birth Defects Res B Dev Reprod Toxicol. 2012;95(1):54–62. doi: 10.1002/bdrb.20341. PubMed DOI

Kihlström I, Lundberg C. Teratogenicity study of the new glucocorticosteroid budesonide in rabbits. Arzneimittelforschung. 1987;37(1):43–46. PubMed

Källén B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93(3):392–395. PubMed

Källén BA, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003;17(3):255–261. doi: 10.1016/s0890-6238(03)00012-1. PubMed DOI

Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin. 2005;21(7):1075–1084. doi: 10.1185/030079905X50570. PubMed DOI

Wilson JG. Plenum Press, New York. 1977. Current status of teratology. In: Handbook of Teratology. Wilson JG and Fraser FC (eds.) p. pp. 47.

Peterka M, Likovsky Z, Peterkova R. Environmental risk and sex ratio in newborns. In: Congenital Diseases and the Environment. In: Nicolopolou-Stamati P, Hens L, Howard CV, editors. Springer. In. 2007. p. pp. 295.

Hendrix N, Berghella V. Non-placental causes of intrauterine growth restriction. Semin Perinatol. 2008;32(3):161–165. doi: 10.1053/j.semperi.2008.02.004. PubMed DOI

Yland JJ, Bateman BT, Huybrechts KF, Brill G, Schatz MX, Wurst KE, Hernández-Díaz S. Perinatal Outcomes Associated with Maternal Asthma and Its Severity and Control During Pregnancy. J Allergy Clin Immunol Pract. 2020;8(6):1928–1937.e3. doi: 10.1016/j.jaip.2020.01.016. PubMed DOI

Peterka M, Havránek T, Jelínek R. Dose-response relationships in chick embryos exposed to embryotoxic agents. Folia Morphol (Praha) 1986;34(1):69–77. PubMed

Peterka M, Mandys V, Viale M, Cafaggi S, Peterková R, Esposito M. Embryotoxicity of cisplatin and a cisplatin-procaine complex (DPR) studied in chick embryo. Neoplasma. 2002;49(6):394–400. PubMed

FDA Guidance Guidance for Industry Reproductive and Developmental Toxicities – Integrating Study Results to Assess Concerns, 2011. Available at: https://www.fda.gov/media/72231/download.

Jelinek R. The Chick Embryotoxicity Screning Test (CHEST). In: Methods in Prenatal Toxicology. In: Neubert D, Merker HJ, Kwasigroch TE, editors. Georg Thieme Publishers, Stuttgard. 1977. p. pp. 381.

Jelinek R, Peterka M. Morphogenetic systems and in vitro techniques in teratology. In: Culture Technique. Applicability for Studies on Prenatal Differentiation and Toxicity. In: Neubert D, Merker HJ, editors. Walter Gruyter, Berlin. 1981. p. pp. 553.

Jelínek R, Marhan O. Validation of the Chick Embryotoxicity Screening Test (CHEST). A comparative study. Funct Dev Morphol. 1994;4(4):317–323. PubMed

Barnes PJ. Glucocorticosteroids. In: Handbook of Experimental Pharmacology. Volume 237. Pharmacology and Therapeutics of Asthma and COPD. In: Barrett JE, Page CP, Barnes PJ, editors. Springer. 2017. p. pp.93. PubMed DOI

Jelínek R, Dostál M. Morphogenesis of cleft palate induced by exogenous factors VII. Mitotic activity during formation of the mouse secondary palate. Folia Morphol (Praha) 1974;22(1):94–101. PubMed

Selroos O. Formoterol used as needed—clinical effectiveness. Respir Med. 2001;95(Suppl B):S17–20. doi: 10.1053/rmed.2001.1141. PubMed DOI

Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol. 2006;117(1):18–24. doi: 10.1016/j.jaci.2005.11.012. quiz 25. PubMed DOI

Dickey BF, Walker JK, Hanania NA, Bond RA. beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010;10(3):254–259. doi: 10.1016/j.coph.2010.03.002. PubMed DOI PMC

Lähelmä S, Kirjavainen M, Kela M, Herttuainen J, Vahteristo M, Silvasti M, Ranki-Pesonen M. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method. Br J Clin Pharmacol. 2005;59(2):167–173. doi: 10.1111/j.1365-2125.2004.02238.x. PubMed DOI PMC

Lähelmä S, Sairanen U, Haikarainen J, Korhonen J, Vahteristo M, Fuhr R, Kirjavainen M. Equivalent lung dose and systemic exposure of budesonide/formoterol combination via easyhaler and turbuhaler. J Aerosol Med Pulm Drug Deliv. 2015;28(6):462–473. doi: 10.1089/jamp.2014.1195. PubMed DOI PMC

Peterka M, Likovsky Z, Panczak A, Peterkova R. Long-term significant seasonal differences in the numbers of new-borns with an orofacial cleft in the Czech Republic – a retrospective study. BMC Pregnancy Childbirth. 2018;18(1):348. doi: 10.1186/s12884-018-1981-0. PubMed DOI PMC